CPIX

CUMBERLAND PHARMACEUTICALS I

CPIX·230770109·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

CPIX (CUMBERLAND PHARMACEUTICALS I) is held by 24 institutional investors as of Q2 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($3.1M), VANGUARD CAPITAL MANAGEMENT LLC ($2.5M), DIMENSIONAL FUND ADVISORS LP ($1.5M). Net institutional sentiment: Bullish.

24
Holders
(2 Elite)
$11M
Total Value
75% (20)
Consensus
15 buying - 5 selling
13F: Insider & Congress: Updated regularly
CPIX

Smart Money Verdict

View all
Loading verdict
Held by 24 funds
2 elite

Who's Trading

Source dates: Price Oct 16, 2026 · Insiders Mar 20, 2026 · Activists Feb 9, 2026 · Congress none

InsiderBJBrown Martin S JRVest 2K shMar 18, 2026
InsiderYCYoung CarolineVest 2K shMar 18, 2026
InsiderKKKrogulski KennethVest 4K shMar 18, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
478,263(+1.6%)$3.1M0.0%+59.64%
27
Increased
379,478(+4.9%)$2.5M0.0%+121.71%
27
Decreased
233,305(-15.6%)$1.5M0.0%+35.99%
0
Decreased
108,413(-5.1%)$702,6160.0%+78.53%
0
Increased
73,391(+341.0%)$475,5740.0%+29.12%
39
Increased
63,547(+11.7%)$411,7850.0%+189.09%
18
Unchanged
58,458$378,8070.0%+298.94%
0
Increased
56,741(+288.4%)$367,6820.0%+33.49%
26
Increased
54,909(+20.4%)$355,8100.0%+98.62%
28
Unchanged
39,510$256,0250.0%+70.98%
0
Increased
26,339(+407.6%)$170,6770.0%+26.32%
25
New
24,014$155,6110.0%+16.36%
31
Increased
23,981(+116.3%)$155,3970.0%+49.14%
36
Increased
21,953(+12.0%)$142,2550.0%+40.13%
17
Unchanged
20,252$131,2330.0%+132.00%
0
Unchanged
19,475$126,1980.0%+337.91%
0
Decreased
14,118(-41.2%)$91,4850.0%+132.00%
0
New
4,544$29,4450.0%+16.36%
30
Increased
3,261(+0.0%)$21,1310.0%+154.68%
13
New
200$1,2960.0%+16.36%
17

Showing 1-20 of 26

1 / 2
CPIXCPIXCUMBERLAND PHARMACEUTICALS I

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used